+8801711525384
Click to know more
Liaison XL
Platform
The fully automated serology test to detect IgG antibodies against SARS-CoV-2.
• A fully automated quantitative solution for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2 • Up to 170 results/hour on LIAISON® XL • Detection of Neutralizing antibodies: 94.4% positive agreement to Plaque Reduction Neutralization Test (PRNT) • High sensitivity and specificity to assure accurate results
Coronavirus disease (COVID-19) is a respiratory infectious disease caused by the newly discovered coronavirus SARS-CoV-2.
COVID-19 and SARS-CoV-2 Timing of seroconversion is a key factor in establishing the appropriate time window to use serology tests. Recent publications indicate that the median for IgG seroconversion is between 9 and 14 days after disease onset. (2,3) Furthermore, since viral RNA can be detected in patients after 20 or more days (4) a positive IgG result should not be interpreted as a sign that a patient has stopped being infective.
Liaison XL
Platform
Click to know more
kit size:
The fully automated serology test to detect IgG antibodies against SARS-CoV-2.
For your information*
Click the logos below
For more information
Click the logos below to discover each of our unique and world leading products for your world class laboratory.
%20(2)_.jpg)
